Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies. - Wikidata - wikimedia - TriplyDB

Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies.

Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies.

http://www.wikidata.org/entity/Q37587362

about

Engineering chimeric antigen receptor-T cells for cancer treatment.

P2860

Q49962991-1F1BE507-8D11-48F7-B757-20184D79D88E

P2860

Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies.

http://www.wikidata.org/entity/Q37587362

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies.

@en

Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies.

@nl

type

label

Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies.

@en

Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies.

@nl

prefLabel

Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies.

@en

Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies.

@nl

P1433

Q37587362-732A31A5-3407-41D2-B1DD-67522F859C58

P1476

Q37587362-DFF57AFC-0B01-4817-98E9-2A183F4A152E

P2093

Q37587362-11E847F1-7622-4BC6-BA52-C06CD3C6D64E

Q37587362-55D71CEC-B149-4979-BFC0-8845476FDEAA

Q37587362-96D57E57-4B33-45DD-920C-419C25369047

Q37587362-D1BAB235-58DA-4C2B-B045-236646C06BCF

P275

Q37587362-FB3AC8DD-B311-436B-9883-5C2CBE097037

P2860

Q37587362-02A1DE20-76FB-4B8C-ABA3-4367A3778151

Q37587362-045C8286-A42B-41F0-B382-DC6BBAE1F856

Q37587362-05B39DB4-40A3-4A81-AE2A-15CE4B3F5490

Q37587362-08C6884E-FAA5-455F-8261-1398250010EF

Q37587362-0B25947E-A01D-4E7D-BD5D-0894A054626B

Q37587362-0FBE3946-B982-4F60-B401-7E9E1FE86CE9

Q37587362-108A7346-9728-4D84-9853-4CE3A048D38E

Q37587362-1D413260-5213-4FB0-B31F-C3895EC7D8DA

Q37587362-22BA8CA9-0194-46D4-8F2A-B3465F9F8291

Q37587362-29A4EA89-5CC4-494E-A483-3AF1B8947849

P304

Q37587362-524CFC46-0148-424E-BED6-805D03ADBFA3

P31

Q37587362-B2DD9909-4FD5-4B8C-9C87-C4202FE71194

P356

Q37587362-A028F829-1E58-426D-9E5F-2902764C508F

P478

Q37587362-D92477AD-037E-4F61-BF99-A6C3CD3D1227

P50

Q37587362-4ADD0D6B-B4F1-418E-8D27-FCCF9CCAFB93

Q37587362-8463ADB7-2DE8-4F17-B8FE-B84218AA7BDD

Q37587362-DF81615A-D2B8-40F5-8C3E-2CD2FA2D8DA3

Q37587362-E31ECE94-C35D-4B09-9990-B2DD9B85842C

P5008

Q37587362-662E9026-D376-42E9-9B28-1DA04D198F24

P577

Q37587362-FB27FECE-F8AC-416C-A6A2-DA623AA593C1

P698

Q37587362-681F5AEB-2C15-48A2-B84D-F861AE9206B6

P921

Q37587362-155892C4-A780-4C06-8478-0F998ED5D4EE

Q37587362-1DDB02E7-4CA9-4AEE-9E3B-6B612CBED4E9

Q37587362-3E70A682-0E56-4EA1-BC8D-71CA7E0AF95A

Q37587362-62907EC9-3881-4A1E-A410-A3D652870927

Q37587362-AE9FAEE7-7DE9-494E-AC73-FEE1C3773C64

Q37587362-CBF55306-BF59-4ADA-98D6-5EEC12AA1380

Q37587362-E740BD19-1925-4D1F-B148-FF423C140E01

Q37587362-F79EEC68-FF3D-438C-9840-1967E0957C0F

P932

Q37587362-2CD9CBE3-FF6D-4D0C-A7C2-1CEF0867808F

P356

P1433

Journal of Immunology Research

P1476

Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies

@en

P2093

Baixin Ye

http://www.w3.org/2001/XMLSchema#string

Qingping Gao

http://www.w3.org/2001/XMLSchema#string

Qiongyu Wang

http://www.w3.org/2001/XMLSchema#string

Zhi Zeng

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

Cancer regression in patients after transfer of genetically engineered lymphocytes

Single-Cell Sequencing Technology in Oncology: Applications for Clinical Therapies and Research

Integrating canonical and metabolic signalling programmes in the regulation of T cell responses

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

Dendritic cells and the control of immunity

P304

5210459

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/5210459

http://www.w3.org/2001/XMLSchema#string

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2017-01-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28116322

http://www.w3.org/2001/XMLSchema#string

P921

hematologic cancer

cell surface receptor

membrane proteins

T-lymphocyte subsets

lymphocyte subsets

biomedical investigative technique

hemic and immune systems

P932

5237740

http://www.w3.org/2001/XMLSchema#string